Akero Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Akero Therapeutics Inc
TickerAKRO
CIK #0001744659
CUSIP00973Y108
SectorLife Sciences - Pharmaceutical Preparations
Address170 Harbor Way, South San Francisco, CA 94080
Source [EDGAR]
CIK Filing 2011 - 2025
[0001744659] 10-K
[0001744659] 10-Q
[0001744659] 3
[0001744659] 4
[0001744659] 8-K
[0001744659] D
[0001744659] SC 13D
[0001744659] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
General Atlantic LP Akero Therapeutics Inc [2024-03-15] 7.7
Price T Rowe Associates Inc /MD/ Akero Therapeutics Inc [2024-02-14] 6.6
RTW Investments LP Akero Therapeutics Inc [2024-02-14] 6.4
Vanguard Group Inc Akero Therapeutics Inc [2024-02-13] 5.54
Wellington Management Group LLP Akero Therapeutics Inc [2024-02-08] 5.17
Adage Capital Partners GP LLC Akero Therapeutics Inc [2023-04-10] 5.97
Baker Bros Advisors LP Akero Therapeutics Inc [2023-02-14] 5.1
Price T Rowe Associates Inc /MD/ Akero Therapeutics Inc [2023-02-14] 5.1
Redmile Group LLC Akero Therapeutics Inc [2023-02-14] 5.6
State Street Corp Akero Therapeutics Inc [2023-02-03] 5.35
BlackRock Inc Akero Therapeutics Inc [2023-02-03] 5.9
BlackRock Inc Akero Therapeutics Inc [2022-11-09] 4.9
Avidity Partners Management LP Akero Therapeutics Inc [2022-09-16] 6.9
Pfizer Inc Akero Therapeutics Inc [2022-06-28] 58.0
Goldman Sachs Group Inc Akero Therapeutics Inc [2022-02-08] 5.1
BlackRock Inc Akero Therapeutics Inc [2022-02-04] 5.6
Wellington Management Group LLP Akero Therapeutics Inc [2022-02-04] 5.38
Point72 Asset Management LP Akero Therapeutics Inc [2021-12-13] 5.0
Skorpios Trust Akero Therapeutics Inc [2021-06-30] 6.7
Redmile Group LLC Akero Therapeutics Inc [2021-02-16] 6.69
Alkeon Capital Management LLC Akero Therapeutics Inc [2021-02-11] 6.6
Janus Henderson Group PLC Akero Therapeutics Inc [2020-02-14] 8.4
Atlas Venture Fund Xi LP Akero Therapeutics Inc [2020-02-13] 0.5
Amgen Inc Akero Therapeutics Inc [2020-02-10] 9.0
Versant Venture Capital VI LP Akero Therapeutics Inc [2019-07-05] 14.7
Apple Tree Partners IV LP Akero Therapeutics Inc [2019-07-01] 19.4
venBio Global Strategic Fund II LP Akero Therapeutics Inc [2019-06-26] 14.17
Form 3/4/5 Filer 2011 - 2025
Akero Therapeutics, Inc.
Gangloff Scott A.
Cheng Andrew
Young Jonathan
Henderson Jane
Rolph Timothy
Yale Catriona
Lamy Patrick
White William Richard
Harrison Seth Loring
Iwicki Mark T
Xu Yuan
Heyman Tomas J.
Graham G. Walmsley
Judy Chou
Montrago Trustees Ltd
Blue Horizon Enterprise Ltd
Skorpios Trust
Ezbon International Ltd
ATP Life Science Ventures, L.P.
ATP III GP, Ltd.
Bitterman Kevin
venBio Global Strategic Fund II L.P.
Goodman Corey S
venBio Global Strategic GP II, L.P.
venBio Global Strategic GP II, Ltd.
Adelman Robert J
Atlas Venture Opportunity Fund I, L.P.
Versant Ventures VI GP-GP, LLC
Versant Ventures VI GP, L.P.
Versant Venture Capital VI, L.P.
Atlas Venture Fund XI, L.P.
Royston Aaron
Atlas Venture Associates XI, L.P.
Atlas Venture Associates Opportunity I, LLC
Atlas Venture Associates XI, LLC
Atlas Venture Associates Opportunity I, L.P.
Redmile Group, LLC
Green Jeremy
Form 13F Holdings
Firm Period DFND Voting Shares
Janus Henderson Group PLC [2025-06-30] DFND 0 6,738,556
BlackRock, Inc. [2025-06-30] SOLE 5,645,501 5,779,412
General Atlantic LP [2025-06-30] SOLE 5,733,989 5,733,989
RTW Investments LP [2025-06-30] SOLE 5,477,561 5,477,561
Vanguard Group Inc [2025-06-30] SOLE 0 4,368,102
Avoro Capital Advisors LLC [2025-06-30] SOLE 3,500,000 3,500,000
Wellington Management Group LLP [2025-06-30] DFND 0 3,409,946
Point72 Asset Management LP [2025-06-30] DFND 0 3,210,929
Deep Track Capital LP [2025-06-30] SOLE 3,042,598 3,042,598
State Street Corp [2025-06-30] DFND 2,568,474 2,745,564
Woodline Partners LP [2025-06-30] SOLE 2,467,350 2,467,350
UBS Group AG [2025-06-30] DFND 2,020,485 2,028,887
Bellevue Group AG [2025-06-30] DFND 1,985,272 1,985,272
Geode Capital Management LLC [2025-06-30] DFND 1,722,405 1,722,405
Alkeon Capital Management LLC [2025-06-30] SOLE 1,552,001 1,552,001
AllianceBernstein LP [2025-06-30] DFND 1,447,538 1,536,200
Marshall Wace LLP [2025-06-30] OTR 0 1,418,215
Citadel Advisors LLC [2025-06-30] DFND 1,363,382 1,363,382
Bank of America Corp /DE/ [2025-06-30] DFND 16,301 1,320,461
Logos Global Management LP [2025-06-30] SOLE 1,200,000 1,200,000
Holocene Advisors LP [2025-06-30] SOLE 1,075,642 1,075,642
Susquehanna International Group LLP [2025-06-30] OTR 207,754 1,073,154
Pictet Asset Management Holding SA [2025-06-30] SOLE 892,560 986,633
FMR LLC [2025-06-30] DFND 928,583 931,926
Perceptive Advisors LLC [2025-06-30] SOLE 915,887 915,887
Goldman Sachs Group Inc [2025-06-30] DFND 793,443 793,641
Redmile Group LLC [2025-06-30] SOLE 774,311 774,311
Long Focus Capital Management LLC [2025-06-30] SOLE 720,000 720,000
SilverArc Capital Management LLC [2025-06-30] SOLE 713,811 713,811
Morgan Stanley [2025-06-30] DFND 641,098 693,256
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com